Bausch Health Companies (BHC) Cash & Current Investments (2009 - 2026)

Bausch Health Companies has disclosed Cash & Current Investments across 18 years of filings, most recently posting $1.3 billion for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $1.3 billion, up 13.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 13.4% YoY), and the FY2025 annual result was $1.3 billion, up 10.32% from the prior year.
• Cash & Current Investments came in at $1.3 billion for Q1 2026 at Bausch Health Companies, down from $1.3 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $2.5 billion in Q1 2022 to a low of $497.0 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $962.0 million (2023), against an average of $1.1 billion.
• Across the five-year window, Cash & Current Investments sank 78.41% in 2023 and surged 179.78% in 2025, its largest moves.
• Bausch Health Companies' Cash & Current Investments stood at $591.0 million in 2022, then jumped by 62.77% to $962.0 million in 2023, then advanced by 24.84% to $1.2 billion in 2024, then grew by 10.32% to $1.3 billion in 2025, then retreated by 0.98% to $1.3 billion in 2026.
• The last three Cash & Current Investments figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.